The post-operative gene test said that the gene mutation was very rare and there was no corresponding therapeutic drug
Hello, if the early and mid-term pulmonary nodules are benign diseases, there is generally no need to do other treatment. If they are malignant, chemotherapy and other treatment can be considered. At present, there are gene mutations, which can be referred to. Other treatments are of little significance. Pay attention to regular review. The early and mid-term effect is relatively good. wish you the best of health
Hello, in the case of nodules, it is generally considered to be benign. According to the current situation described by you, but in the case of gene mutation, in the later stage, you can only review your current nodules regularly. It is suggested that you should also make a further pathological examination, which can be judged after a pathological examination. You can judge the nature of the nodule.
This shows that you can't carry out targeted therapy. Just observe temporarily and have a look. If there is no way to carry out targeted therapy for this chemotherapy, it is actually a good thing for you. It shows that there is no mutation in the gene and regular follow-up review is needed